Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Khalid

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
JMIR Research Protocols|September 15, 2016
Protocol Outlines for Parts 1 and 2 of the Prospective Endoscopy III Study for the Early Detection of Colorectal Cancer: Validation of a Concept Based on Blood BiomarkersLouise Rasmussen, Michael Wilhelmsen, Ib Jarle Christensen, et al.
American Journal of Hematology|September 27, 2024
PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosisAyalew Tefferi, Saubia Fathima, Ali Khalid A Alsugair, et al.
Frontiers in Chemistry|December 13, 2023
Towards sustainable electrochemistry: green synthesis and sintering aid modulations in the development of BaZr<sub>0.87</sub>Y<sub>0.1</sub>M<sub>0.03</sub>O<sub>3-δ</sub> (M = Mn, Co, and Fe) IT-SOFC electrolytesQurat Ul Ain, Muneeb Irshad, Muhammad Salim Butt, et al.
Clinical Colorectal Cancer|March 6, 2023
Optimizing Screening for Colorectal Cancer: An Algorithm Combining Fecal Immunochemical Test, Blood-Based Cancer-Associated Proteins and Demographics to Reduce Colonoscopy BurdenMathias M Petersen, Jakob Kleif, Lars N Jørgensen, et al.
Blood Cancer Journal|April 4, 2026
One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-molMuhammad Yousuf, Saubia Fathima, Ali Khalid A Alsugair, et al.
The Journal of Infection|January 16, 2023
Oseltamivir is protective for in-patient mortality in PCR confirmed influenza B and influenza A(H3N2) infections in an historic cohort of 1,048 patients hospitalised during the 2016-17 and 2017-18  influenza seasonsMark Reacher, Ben Warne, Neville Q Verlander, et al.
Leukemia|June 24, 2025
Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypesClifford M Csizmar, Anuya Natu, Mark Gurney, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
JMIR Research Protocols|September 15, 2016
Protocol Outlines for Parts 1 and 2 of the Prospective Endoscopy III Study for the Early Detection of Colorectal Cancer: Validation of a Concept Based on Blood BiomarkersLouise Rasmussen, Michael Wilhelmsen, Ib Jarle Christensen, et al.
American Journal of Hematology|September 27, 2024
PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosisAyalew Tefferi, Saubia Fathima, Ali Khalid A Alsugair, et al.
Frontiers in Chemistry|December 13, 2023
Towards sustainable electrochemistry: green synthesis and sintering aid modulations in the development of BaZr<sub>0.87</sub>Y<sub>0.1</sub>M<sub>0.03</sub>O<sub>3-δ</sub> (M = Mn, Co, and Fe) IT-SOFC electrolytesQurat Ul Ain, Muneeb Irshad, Muhammad Salim Butt, et al.
Clinical Colorectal Cancer|March 6, 2023
Optimizing Screening for Colorectal Cancer: An Algorithm Combining Fecal Immunochemical Test, Blood-Based Cancer-Associated Proteins and Demographics to Reduce Colonoscopy BurdenMathias M Petersen, Jakob Kleif, Lars N Jørgensen, et al.
Blood Cancer Journal|April 4, 2026
One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-molMuhammad Yousuf, Saubia Fathima, Ali Khalid A Alsugair, et al.
The Journal of Infection|January 16, 2023
Oseltamivir is protective for in-patient mortality in PCR confirmed influenza B and influenza A(H3N2) infections in an historic cohort of 1,048 patients hospitalised during the 2016-17 and 2017-18  influenza seasonsMark Reacher, Ben Warne, Neville Q Verlander, et al.
Leukemia|June 24, 2025
Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypesClifford M Csizmar, Anuya Natu, Mark Gurney, et al.
Pageof 7